• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » A record year for device innovation

A record year for device innovation

February 15, 2019 By Danielle Kirsh

imarcEmily Zetzer, clinical research associate, IMARC

Recently FDA Commissioner Scott Gottlieb released a statement on a record year for device innovation. This press release highlights the FDA’s efforts for advancement of medical devices that serve previously unmet medical need, improve quality of life, and in some cases save lives.

The FDA’s efforts to continue the advancement of device innovation was highlighted in 2018 by a record number of novel device approvals (106), surpassing previous years and the approval of nine breakthrough devices.

During 2018 the FDA released several statements outlining their efforts to ensure safety while fostering innovation with their modernized approach to device safety, and most recently their plans to further modernize the 510(k) clearance pathway. As a result of the recent changes to modernize the 510(k) program the FDA recently released another guidance outlining an alternative to the 510(k) pathway with a focus on improved safety and performance of new products.

FDA Commissioner Scott Gottlieb emphasized that the FDA is committed to improving patient safety and fostering innovation in the coming year. This commitment includes the continued development of the National Evaluation System for Health Technology (NEST). NEST is a collaborative national evaluation system being built by the FDA to capture data throughout the lifecycle of medical devices. The aim is to improve the quality of information available for healthcare providers and patients to make more informed decisions, while making the medical device evaluation process more efficient.

The FDA also expects to release a plan for the “Safer Technologies Program (STeP)”. This program will further analyze how the standards of the Breakthrough Device Program can be applied to improved products aimed to treat or diagnose non-life-threatening diseases and conditions.

As the FDA continues to improve safety and greater innovation; Scott Gottlieb recognizes that it’s essential for the FDA to not only stay ahead of the product advancements to come but be willing to embrace and lead change.

What are your thoughts on the current plans to improve patient safety and foster medical device innovation?

The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MassDevice.com or its employees.

Filed Under: Blog Tagged With: IMARC

More recent news

  • Perfuze’s super-bore stroke catheter tops conventional, cyclic aspiration in bench study
  • Edwards Lifesciences taps GE HealthCare vet to head new digital engineering group
  • Abbott partners with Berry Street to add nutrition coaching to Lingo
  • GE HealthCare taps retiring AT&T CFO for board of directors
  • Corcym delivers first-in-human implant of Memo 4D Curve mitral repair ring

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Design & Outsourcing, MassDevice, and Medical Tubing + Extrusion, and the founder of Women in Medtech and lead editor for Big 100. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy